13
Expenditure on R&D:
Rs. Lakhs
Capital
5.60
Recurring
240.35
Total:
245.95
Total R&D expenditure as a percentage of turnover
0.10%
GSK plc the parent organization of your Company is one of the biggest investors in R&D to bring
new products and vaccines to the market. Your company has been a beneficiary of this significant
investment in R&D and it is the effort of the parent organization which has enabled your Company
to bring a number of new drugs to market since inception.
Technology Absorption, Adaptation and Innovation:
•
Installed the latest High speed high precision tablet compression machine for Zinetac
& Eltroxin.
•
To cope up with the increased demand of products in the derma portfolio a high speed
automated packaging line has been installed.
III. Foreign Exchange Earnings and Outgo
Activities relating to exports, initiatives taken to increase exports, development of new export
markets for products and services and export plans:
(1) Exports amounted to Rs. 1959 lakhs for the year.
(2) Total Foreign Exchange used and earned :
During the 12 month period, the foreign exchange outgo was Rs. 41414 lakhs (which includes
amounts spent on import of raw and packing materials and finished goods aggregating to
Rs. 20259 lakhs and Dividend payment of Rs. 19313 lakhs) as compared to Rs. 36418 lakhs
in 2011. The foreign exchange earned was Rs. 7152 lakhs mainly on account of exports and
clinical research and data management as compared to Rs. 7987 lakhs in 2011. Details have
been given in Notes 42 to 45 to the financial statements.
1...,7,8,9,10,11,12,13,14,15,16 18,19,20,21,22,23,24,25,26,27,...102